| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 06/03/2004 | WO2004046693A1 Instrument for collecting and recovering saliva |
| 06/03/2004 | WO2004046690A2 Composite sensor membrane |
| 06/03/2004 | WO2004046689A2 System and method for multiplexed biomolecular analysis |
| 06/03/2004 | WO2004046687A2 Methods of biosensing using fluorescent polymers and quencher-tether-ligand bioconjugates |
| 06/03/2004 | WO2004046686A2 Method and system for analyzing test devices |
| 06/03/2004 | WO2004046685A2 Quality control of assays |
| 06/03/2004 | WO2004046684A2 Mixed potential hydrocarbon sensor with low sensitivity to methane and co |
| 06/03/2004 | WO2004046683A2 Detection of cellular or dna damage based upon hr23 protein binding molecules |
| 06/03/2004 | WO2004046382A2 Product and method |
| 06/03/2004 | WO2004046377A2 Diagnostic and therapeutic means for pathologies associated with alpha 2 subunit of the na, k pump |
| 06/03/2004 | WO2004046376A2 Methods and kits for diagnosing and treating b-cell chronic lymphocytic leukemia (b-cll) |
| 06/03/2004 | WO2004046355A2 Protein specific to pancreatic beta cells in islets of langerhans and applications thereof |
| 06/03/2004 | WO2004046339A2 Caged sensors, regulators and compounds and uses thereof |
| 06/03/2004 | WO2004046337A2 Multilayered microcultures |
| 06/03/2004 | WO2004046329A2 Levels of pin1 in normal and cancerous tissue |
| 06/03/2004 | WO2004046317A2 Products and processes for modulating peptide-peptide binding domain interactions |
| 06/03/2004 | WO2004046314A2 Methods for detecting asymmetric dimethylarginine in a biological sample |
| 06/03/2004 | WO2004046310A2 Novel mouse polypeptides encoded by polynucleotides and methods of their use |
| 06/03/2004 | WO2004046194A2 Polyclonal-monoclonal elisa assay for detecting n-terminus probnp |
| 06/03/2004 | WO2004046182A2 Use of soluble forms of cd83 and nucleic acids encoding them for the treatment or prevention of diseases |
| 06/03/2004 | WO2004046181A1 Sandwich immunoassay for identifying partial proanp peptides |
| 06/03/2004 | WO2004046164A2 Unique recognition sequences and methods of use thereof in protein analysis |
| 06/03/2004 | WO2004046155A2 Predicting outcome of hyperbaric oxygen therapy treatment with nitric oxide bioavailability |
| 06/03/2004 | WO2004046100A2 Release of the self-quenching of fluorescence near silver metallic surfaces |
| 06/03/2004 | WO2004045770A1 Blood testing apparatus |
| 06/03/2004 | WO2004045559A2 Method for the prevention of malaria |
| 06/03/2004 | WO2004045556A2 Methods for inhibiting allergic inflammation and other responses initiated by pollens, molds, and other non-animal derived allergens |
| 06/03/2004 | WO2004045547A2 Rnai-based sensors, caged interfering rnas, and methods of use thereof |
| 06/03/2004 | WO2004045545A2 Compositions and methods for the treatment of cancer, screening of putative anti-cancer compounds, and assessing cancer progression |
| 06/03/2004 | WO2004045544A2 Autocrine growth factor receptor antibodies and methods |
| 06/03/2004 | WO2004045543A2 Functional and hyperfunctional sirna |
| 06/03/2004 | WO2004045535A2 Molecular interactions in neurons |
| 06/03/2004 | WO2004045532A2 Methods for preventing and treating cancer metastasis and bone loss associated with cancer metastasis |
| 06/03/2004 | WO2004045521A2 Detection of micro metastasis of melanoma and breast cancer in paraffin-embedded tumor draining lymph nodes by multimaker quantitative rt-pcr |
| 06/03/2004 | WO2004045519A2 Induction of apoptosis by hiv-1 infected monocytic cells |
| 06/03/2004 | WO2004045517A2 Method for the diagnosis and treatment of vascular disease |
| 06/03/2004 | WO2004045516A2 Compositions and methods for the diagnosis and treatment of tumor |
| 06/03/2004 | WO2004045512A2 Human monoclonal antibodies against cd25 |
| 06/03/2004 | WO2004045499A2 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases |
| 06/03/2004 | WO2004045495A2 Interacting site for gp41 on gp120 of hiv-1 |
| 06/03/2004 | WO2004045381A2 Immunoassay device for diagnosing congestive heart failure |
| 06/03/2004 | WO2004045379A2 Biomarkers for intra-amniotic inflammation |
| 06/03/2004 | WO2004045376A2 Screening methods to identify treatments for autoimmune disease |
| 06/03/2004 | WO2004045371A2 Methods for diagnosing the presence or stage of cancer |
| 06/03/2004 | WO2004045369A2 Nuclear receptor-based diagnostic, therapeutic, and screening methods |
| 06/03/2004 | WO2004045364A2 Methods of detecting ovarian neoplasia |
| 06/03/2004 | WO2004039401A3 Use of antibodies to the gamma 2 chain of lallminin 5 to inhibit tumor growth and metastasis |
| 06/03/2004 | WO2004036205A3 Molecular weight marker kit for proteins and method for producing the same |
| 06/03/2004 | WO2004034062A3 Use of cap-1 for the therapy of asthma |
| 06/03/2004 | WO2004033723A3 Neurodegenerative disease-associated gene |
| 06/03/2004 | WO2004033062A9 Integrated sample cell and filter and system using same |
| 06/03/2004 | WO2004031397A9 Detection of evolutionary bottlenecking by dna sequencing as a method to discover genes of value |
| 06/03/2004 | WO2004031332A3 System for identifying the lubricating oil in a machine |
| 06/03/2004 | WO2004029298A3 Mitochondrial dna autoscoring system |
| 06/03/2004 | WO2004029093A3 Humanized anti-granulocyte mn-3 antibody and uses thereof |
| 06/03/2004 | WO2004026697A3 System and method of storing and retrieving storage elements |
| 06/03/2004 | WO2004026109A9 Molecular targets of cancer and aging |
| 06/03/2004 | WO2004025416A3 Bioinformatic method for identifying surface-anchored proteins from gram-positive bacteria and proteins obtained thereby |
| 06/03/2004 | WO2004025295A3 Process and apparatus comprising episcopoc differential contrast (edic) microscopy plus epifluorescence microscopy (ef) for the detection or identification of biological materials on surfaces |
| 06/03/2004 | WO2004024904A3 Infectious hepacivirus pseudo-particles containing functional e1, e2 envelope proteins |
| 06/03/2004 | WO2004024328B1 Method and apparatus for aligning elongated microbeads in order to interrogate the same |
| 06/03/2004 | WO2004024084A9 Rb pahtway and chromatin remodeling genes that antagonize let-60 ras signaling |
| 06/03/2004 | WO2004023972A3 Monitoring blood glucose including convenient display of measurement values ________________________________________________________ |
| 06/03/2004 | WO2004022708A3 Genes and proteins altering tau-related neurodegeneration |
| 06/03/2004 | WO2004018515A3 T-cell epitopes in erythropoietin |
| 06/03/2004 | WO2004017052A3 Histological assessment |
| 06/03/2004 | WO2004013306A3 Drosophila g protein coupled receptors, nucleic acids, and methods related to the same |
| 06/03/2004 | WO2004013204A3 Polymer extraction methods |
| 06/03/2004 | WO2004011945A3 Molecular markers for cholangiolar carcinoma |
| 06/03/2004 | WO2004008129A3 Method and device for monitoring moisture content of an immersed solid dielectric material |
| 06/03/2004 | WO2004007725A9 Polypeptide of streptococcus pyogenes |
| 06/03/2004 | WO2004005929A3 Methods and formulations for diagnosing, monitoring, staging and treating heart failure |
| 06/03/2004 | WO2004002513A3 Proteins involved in the regulation of energy homeostasis |
| 06/03/2004 | WO2004001379A3 Methods and compositions for detection and analysis of polynucleotides using light harvesting multichromophores |
| 06/03/2004 | WO2003106974A3 Diagnosis and treatment of chemoresistant tumors |
| 06/03/2004 | WO2003104813A3 Modification of polypeptides for characterisation purposes |
| 06/03/2004 | WO2003100432A3 Method for identifying immunoreactive peptides |
| 06/03/2004 | WO2003100024A3 Treatment for diabetes |
| 06/03/2004 | WO2003099107A3 Methods and kits for the detection of renal cell carcinoma in a biological fluid of a patient |
| 06/03/2004 | WO2003096022A8 Screening for peptides inhibiting pp1c binding to bcl-2, bcl-xl and bcl-w proteins |
| 06/03/2004 | WO2003089896A8 Rapid assay, method and system for detecting biowarfare agents |
| 06/03/2004 | WO2003089580A3 Cancer models |
| 06/03/2004 | WO2003087326A3 Automated protein crystallization imaging |
| 06/03/2004 | WO2003079025A3 Methods for the identification of compounds useful for the suppression of chronic neuropathic pain and compositions thereof |
| 06/03/2004 | WO2003076945A3 Diagnostic for diseases associated with g-protein coupled receptor 105 (gpr105) |
| 06/03/2004 | WO2003069345A3 Analysis of a protein expression pattern |
| 06/03/2004 | WO2003065012A3 Compositions and methods for reporting of protease activity within the secretory pathway |
| 06/03/2004 | WO2003060477A3 Iterative optical based histology |
| 06/03/2004 | WO2003057159A9 Psoriasin expression by breast epithelial cells |
| 06/03/2004 | WO2003054544A3 Method for determination of the responsiveness of an individual to mistletoe lectin |
| 06/03/2004 | WO2003042654A3 Multi-parameter high throughput screening assays (mphts) |
| 06/03/2004 | WO2003037930A8 Novel human n-methyl-d-asparatate (nmda) glutamate receptor polypeptide and gene encoding the same |
| 06/03/2004 | WO2003035894A8 Multiparameter analysis of comprehensive nucleic acids and morphological features on the same sample |
| 06/03/2004 | WO2003020739A3 Novel lna compositions and uses thereof |
| 06/03/2004 | WO2003018610A8 Peptides of melanoma antigen and their use in diagnostic, prophylactic and therapeutic methods |
| 06/03/2004 | WO2003016567A3 Conformation-activity relationship of apoptosis-inducing phosphodiester oligonucleotides |
| 06/03/2004 | WO2003006104A8 Lymphatic endothelial cells materials and methods |
| 06/03/2004 | WO2003000928A3 Methods for identification of cancer cell surface molecules and cancer specific promoters, and therapeutic uses thereof |
| 06/03/2004 | WO2002102846B1 Pharmaceutical composition for diagnosis, prevention or treatment of a tumorous state, comprising a modulator of the actin polymerisation state |
| 06/03/2004 | WO2002077636A8 Volatile signature detector and associated methods |